BMS swoops on Forbius, snaring another immuno-oncology playerWith the ink barely dry on a deal to develop Dragonfly’s lead cancer immunotherapy, Bristol-Myers Squibb’s business development Share XBMS swoops on Forbius, snaring another immuno-oncology playerhttps://pharmaphorum.com/news/bms-swoops-on-forbius-snaring-another-immuno-oncology-player/